These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

132 related items for PubMed ID: 3896347

  • 1. Use of multiple T cell-directed intact ricin immunotoxins for autologous bone marrow transplantation.
    Stong RC, Uckun F, Youle RJ, Kersey JH, Vallera DA.
    Blood; 1985 Sep; 66(3):627-35. PubMed ID: 3896347
    [Abstract] [Full Text] [Related]

  • 2. Elimination of clonogenic T-leukemic cells from human bone marrow using anti-Mr 65,000 protein immunotoxins.
    Stong RC, Youle RJ, Vallera DA.
    Cancer Res; 1984 Jul; 44(7):3000-6. PubMed ID: 6372999
    [Abstract] [Full Text] [Related]

  • 3. Anti-CD2 (T, p50) intact ricin immunotoxins for GVHD-prophylaxis in allogeneic bone marrow transplantation.
    Uckun FM, Azemove SM, Myers DE, Vallera DA.
    Leuk Res; 1986 Jul; 10(2):145-53. PubMed ID: 3512922
    [Abstract] [Full Text] [Related]

  • 4. Use of colony assays and anti-T cell immunotoxins to elucidate the immunobiologic features of leukemic progenitor cells in T-lineage acute lymphoblastic leukemia.
    Uckun FM, Myers DE, Ledbetter JA, Swaim SE, Gajl-Peczalska KJ, Vallera DA.
    J Immunol; 1988 Mar 15; 140(6):2103-11. PubMed ID: 3126241
    [Abstract] [Full Text] [Related]

  • 5. Antigenic modulation by anti-CD5 immunotoxins.
    Manske JM, Buchsbaum DJ, Azemove SM, Hanna DE, Vallera DA.
    J Immunol; 1986 Jun 15; 136(12):4721-8. PubMed ID: 3086441
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined ex vivo treatment with immunotoxins and mafosfamid: a novel immunochemotherapeutic approach for elimination of neoplastic T cells from autologous marrow grafts.
    Uckun FM, Stong RC, Youle RJ, Vallera DA.
    J Immunol; 1985 May 15; 134(5):3504-15. PubMed ID: 3884712
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Anti-MY9-blocked-ricin: an immunotoxin for selective targeting of acute myeloid leukemia cells.
    Roy DC, Griffin JD, Belvin M, Blättler WA, Lambert JM, Ritz J.
    Blood; 1991 Jun 01; 77(11):2404-12. PubMed ID: 2039821
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. An immunotoxin with therapeutic potential in T cell leukemia: WT1-ricin A.
    Myers CD, Thorpe PE, Ross WC, Cumber AJ, Katz FE, Tax W, Greaves MF.
    Blood; 1984 May 01; 63(5):1178-85. PubMed ID: 6370334
    [Abstract] [Full Text] [Related]

  • 13. Anti-T cell immunotoxins containing pokeweed anti-viral protein: potential purging agents for human autologous bone marrow transplantation.
    Ramakrishnan S, Uckun FM, Houston LL.
    J Immunol; 1985 Nov 01; 135(5):3616-22. PubMed ID: 3900212
    [Abstract] [Full Text] [Related]

  • 14. Marrow purging in autologous bone marrow transplantation for T-lineage acute lymphoblastic leukemia: efficacy of ex vivo treatment with immunotoxins and 4-hydroperoxycyclophosphamide against fresh leukemic marrow progenitor cells.
    Uckun FM, Gajl-Peczalska K, Meyers DE, Ramsay NC, Kersey JH, Colvin M, Vallera DA.
    Blood; 1987 Jan 01; 69(1):361-6. PubMed ID: 3098325
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Specific ex-vivo depletion of human bone marrow T lymphocytes by an anti-pan-T cell (CD5) ricin A-chain immunotoxin.
    Siena S, Villa S, Bonadonna G, Bregni M, Gianni AM.
    Transplantation; 1987 Mar 01; 43(3):421-6. PubMed ID: 3103275
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Graft-versus-host disease prevention in allogeneic bone marrow transplantation from histocompatible siblings. A pilot study using immunotoxins for T cell depletion of donor bone marrow.
    Filipovich AH, Vallera DA, Youle RJ, Haake R, Blazar BR, Arthur D, Neville DM, Ramsay NK, McGlave P, Kersey JH.
    Transplantation; 1987 Jul 01; 44(1):62-9. PubMed ID: 3299923
    [Abstract] [Full Text] [Related]

  • 20. Evidence for absence of toxicity of T101 immunotoxin on human hematopoietic progenitor cells prior to bone marrow transplantation.
    Douay L, Gorin NC, Lopez M, Casellas P, Liance MC, Jansen FK, Voisin GA, Baillou C, Laporte JP, Najman A.
    Cancer Res; 1985 Jan 01; 45(1):438-41. PubMed ID: 3880666
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.